Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level

Liselotte C. van Asten; Faroudy Boufassa; Veronique Schiffer; Raymond P. Brettle; J. Roy Robertson; Ildefonso Hernández Aguado; Jim McMenamin; Robert Zangerle; Arnaud Fontanet; Roel A. Coutinho; Maria Prins

doi:https://doi.org/10.1093/eurpub/13.4.347

Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level

Liselotte C. van Asten, Faroudy Boufassa, Veronique Schiffer, Raymond P. Brettle, J. Roy Robertson, Ildefonso Hernández Aguado, Jim McMenamin, Robert Zangerle, Arnaud Fontanet, Roel A. Coutinho, Maria Prins

Infectious diseases (AMC)

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Abstract

There is evidence that HIV-positive injecting drug users benefit less than other risk groups from highly active antiretroviral therapy that has been available since 1996. In this multicentre European study the impact of the availability of highly active antiretroviral therapy on the progression rates to AIDS and death among injecting drug users with a documented date of HIV seroconversion is studied. After highly active antiretroviral therapy became available the risk of AIDS and death for injecting drug users decreased by 28% and 36%, which is less than has been reported for other risk groups

Original language	English
Pages (from-to)	347-349
Journal	European journal of public health
Volume	13
Issue number	4
DOIs	https://doi.org/10.1093/eurpub/13.4.347
Publication status	Published - 2003

Access to Document

https://doi.org/10.1093/eurpub/13.4.347

Cite this

van Asten, L. C., Boufassa, F., Schiffer, V., Brettle, R. P., Robertson, J. R., Hernández Aguado, I., McMenamin, J., Zangerle, R., Fontanet, A., Coutinho, R. A., & Prins, M. (2003). Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. European journal of public health, 13(4), 347-349. https://doi.org/10.1093/eurpub/13.4.347

@article{1509a53702c24ba0aef840fd5f5a2021,

title = "Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level",

abstract = "There is evidence that HIV-positive injecting drug users benefit less than other risk groups from highly active antiretroviral therapy that has been available since 1996. In this multicentre European study the impact of the availability of highly active antiretroviral therapy on the progression rates to AIDS and death among injecting drug users with a documented date of HIV seroconversion is studied. After highly active antiretroviral therapy became available the risk of AIDS and death for injecting drug users decreased by 28% and 36%, which is less than has been reported for other risk groups",

author = "{van Asten}, {Liselotte C.} and Faroudy Boufassa and Veronique Schiffer and Brettle, {Raymond P.} and Robertson, {J. Roy} and {Hern{\'a}ndez Aguado}, Ildefonso and Jim McMenamin and Robert Zangerle and Arnaud Fontanet and Coutinho, {Roel A.} and Maria Prins",

year = "2003",

doi = "https://doi.org/10.1093/eurpub/13.4.347",

language = "English",

volume = "13",

pages = "347--349",

journal = "European journal of public health",

issn = "1101-1262",

publisher = "Oxford University Press",

number = "4",

}

van Asten, LC, Boufassa, F, Schiffer, V, Brettle, RP, Robertson, JR, Hernández Aguado, I, McMenamin, J, Zangerle, R, Fontanet, A, Coutinho, RA & Prins, M 2003, 'Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level', European journal of public health, vol. 13, no. 4, pp. 347-349. https://doi.org/10.1093/eurpub/13.4.347

TY - JOUR

T1 - Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level

AU - van Asten, Liselotte C.

AU - Boufassa, Faroudy

AU - Schiffer, Veronique

AU - Brettle, Raymond P.

AU - Robertson, J. Roy

AU - Hernández Aguado, Ildefonso

AU - McMenamin, Jim

AU - Zangerle, Robert

AU - Fontanet, Arnaud

AU - Coutinho, Roel A.

AU - Prins, Maria

PY - 2003

Y1 - 2003

N2 - There is evidence that HIV-positive injecting drug users benefit less than other risk groups from highly active antiretroviral therapy that has been available since 1996. In this multicentre European study the impact of the availability of highly active antiretroviral therapy on the progression rates to AIDS and death among injecting drug users with a documented date of HIV seroconversion is studied. After highly active antiretroviral therapy became available the risk of AIDS and death for injecting drug users decreased by 28% and 36%, which is less than has been reported for other risk groups

AB - There is evidence that HIV-positive injecting drug users benefit less than other risk groups from highly active antiretroviral therapy that has been available since 1996. In this multicentre European study the impact of the availability of highly active antiretroviral therapy on the progression rates to AIDS and death among injecting drug users with a documented date of HIV seroconversion is studied. After highly active antiretroviral therapy became available the risk of AIDS and death for injecting drug users decreased by 28% and 36%, which is less than has been reported for other risk groups

U2 - https://doi.org/10.1093/eurpub/13.4.347

DO - https://doi.org/10.1093/eurpub/13.4.347

M3 - Article

C2 - 14703322

SN - 1101-1262

VL - 13

SP - 347

EP - 349

JO - European journal of public health

JF - European journal of public health

IS - 4

ER -